Overview
- 3 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 1 investigator is tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
15 Apr 2026
ISO 13485:2016 Clause 7.1
Processes needed for product realization not planned and developed
Cited by Marlo-Ian M Alintanahin
15 Apr 2026
ISO 13485:2016 Clause 7.3.10
Design and development files not maintained
Cited by Marlo-Ian M Alintanahin
15 Apr 2026
ISO 13485:2016 Clause 7.5.6
Process for production and service provision not validated
Cited by Marlo-Ian M Alintanahin
Inspected site
SPScientific Pharmaceuticals, Inc.Pomona, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| ISO 13485:2016 Clause 7.1 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 7.3.10 | Cited across public-safe Form 483 observations | 1x |
| ISO 13485:2016 Clause 7.5.6 | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 3 observations
The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere